When should pregnant women get the RSV vaccine? Research suggests that 32 weeks into pregnancy ensures the best antibody ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

The "Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2024" report ...

About 35% of adults got a flu shot, while 18% received the updated COVID-19 vaccine by early November, the CDC report said.

KALAMAZOO, Mich. — A new antibody shot could help infants who contract respiratory syncytial virus, or RSV. Beyfortus is a ...

Respiratory illness season has begun, and state and local health officials encourage everyone to protect themselves and their ...

The three big respiratory viruses that surge during this time of the year are mostly low in California and nationwide. Flu is ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

Respiratory virus activity remained low in the United States last week, with COVID levels continuing to decline, but ...

Pregnant women should receive the RSV vaccine Abrysvo between 32-36 weeks' gestation, with no significant preterm birth risk observed. Respiratory virus season is here, according to David Ha, PharmD, ...

No writing assistance was utilized in the production of this manuscript. Worldwide, respiratory syncytial virus (RSV) is the most important cause of bronchiolitis and pneumonia in infants.